NCT05870540 BPL-003 Efficacy and Safety in Treatment Resistant Depression Status COMPLETED Phase PHASE2
NCT05849402 Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder Status RECRUITING Phase NA
NCT05838560 Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05833087 Schema Therapy for Patients With Chronic Treatment Resistant Depression Status RECRUITING Phase NA
NCT05811104 Accelerated High-dose Sequential Bilateral Theta Burst Stimulation for Treatment Resistant Depression Status UNKNOWN Phase NA
NCT05798143 Translational Biomarkers in Accelerated Neuromodulation for Treatment-resistant Depression Status RECRUITING Phase NA
NCT05774665 Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression Status COMPLETED Phase PHASE2
NCT05711940 Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05680220 40 Hz Light Neurostimulation for Patients With Depression (FELIX) Status RECRUITING Phase NA
NCT05660642 An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression Status RECRUITING Phase PHASE2
NCT05625555 Predictors of Intravenous Ketamine Response in TRD Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05624268 Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05615948 Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression Status COMPLETED Phase PHASE4
NCT05598931 Development of Neuro-Navigated Transcranial Magnetic Stimulation (TMS) Using MRI Status COMPLETED Phase N/A
NCT05595356 Home-based Transcranial Direct Current Stimulation for Treatment Resistant Depression Status RECRUITING Phase NA